Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hidden scar breast reconstruction: endoscopic technique spares muscle

NCT ID NCT03838549

Disease control Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new surgical method for immediate breast reconstruction after preventive mastectomy in women at high genetic risk for breast cancer. Instead of a scar on the breast, surgeons used a single-port endoscope through the armpit to place the implant under the skin, without cutting the chest muscle. The goal was to reduce complications and improve cosmetic results. The study included 20 women with small to medium breast size and minimal sagging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Apr 2019

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient with an indication for prophylactic uni or bilateral mastectomy (Genetic risk factors for breast cancer) * Ask an immediate breast reconstruction during the surgery * World Heath Organization score \<3 * Glandular volume : french bra cup size A, B ou C * Glandular ptosis \<=2 (Classification and Algorithm for Treatment of Breast Ptosis) * Contraception for woman of childbearing age and no pregnancy * Valid Social Security * Wrote consent Exclusion Criteria: * History of breast cancer surgery * Breast cancer not operated on the side concerned by the prophylactic mastectomy * Patient having had irradiant treatment * Breast hypertrophy * Smoking \> 10 cigarette/day * Body Mass Index \> 30 * Large breast volume requiring prostheses \> 500ml * Chronic pulmonary obstructive gold 4 * ASA (Physical Status score of American Society of Anesthesiologists) \> 3 * Chronic shoulder pain on the side to operate, or both shoulders * History of abarticular pathology of the shoulder on the operating side * Patient involvment in another clinical research * Protected patient or unable to give consent * Pregnant or breastfeeding woman * Vulnerable person (Article L1121-6 of the Public Health Code)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast neoplasm inherited disease susceptibility breast cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Genetic predisposition

Contacts and locations

Locations

  • Montpellier University Hospital

    Montpellier, Hérault, 34295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.